Overexpression of systemic immunosuppressive soluble factors by glioma cells, such as PTGS2 (rate-limiting step catalyzed by COX-2), TGFB1, IDO1, and IL-10 [38], were also investigated at the transcriptional level (Fig. 5A-B). This evidence concerns the gene IDO1 and central nervous system cancer.